Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[State of the art and advances in radiotherapy for bladder cancer].
Thariat J, Caullery M, Ginot A, Hannoun-Lévi JM, Barrière J, Buthaud X, Marcié S, Bondiau PY, Housset M, Lagrange JL, Amiel J, Gérard JP. Thariat J, et al. Among authors: buthaud x. Prog Urol. 2009 Feb;19(2):85-93. doi: 10.1016/j.purol.2008.11.002. Epub 2008 Dec 16. Prog Urol. 2009. PMID: 19168010 French.
Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.
Goineau A, Campion L, d'Aillières B, Vié B, Ghesquière A, Béra G, Jaffres D, de Laroche G, Magné N, Artignan X, Chamois J, Bergerot P, Martin E, Créhange G, Deniaud-Alexandre E, Buthaud X, Belkacémi Y, Doré M, de Decker L, Supiot S. Goineau A, et al. Among authors: buthaud x. PLoS One. 2018 Apr 9;13(4):e0194173. doi: 10.1371/journal.pone.0194173. eCollection 2018. PLoS One. 2018. PMID: 29630602 Free PMC article.
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Vaugier L, Palpacuer C, Rio E, Goineau A, Pasquier D, Buthaud X, De Laroche G, Beckendorf V, Sargos P, Créhange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Campion L, Supiot S. Vaugier L, et al. Among authors: buthaud x. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1061-1067. doi: 10.1016/j.ijrobp.2018.12.020. Epub 2018 Dec 14. Int J Radiat Oncol Biol Phys. 2019. PMID: 30557672 Free article. Clinical Trial.
Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75 Years or Older?
Goineau A, Campion L, Commer JM, Vié B, Ghesquière A, Béra G, Jaffres D, Magné N, Artignan X, Chamois J, Bergerot P, Créhange G, Deniaud-Alexandre E, Buthaud X, Belkacémi Y, Doré M, De Decker L, Supiot S. Goineau A, et al. Among authors: buthaud x. Cancers (Basel). 2020 Mar 9;12(3):635. doi: 10.3390/cancers12030635. Cancers (Basel). 2020. PMID: 32182949 Free PMC article.
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A. Supiot S, et al. Among authors: buthaud x. Eur Urol. 2021 Oct;80(4):405-414. doi: 10.1016/j.eururo.2021.06.010. Epub 2021 Jul 8. Eur Urol. 2021. PMID: 34247896 Clinical Trial.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Vaugier L, Morvan C, Pasquier D, Buthaud X, Magné N, Beckendorf V, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Paul J, Blanc-Lapierre A, Supiot S. Vaugier L, et al. Among authors: buthaud x. Eur Urol. 2025 Jan;87(1):73-76. doi: 10.1016/j.eururo.2024.02.013. Epub 2024 Mar 14. Eur Urol. 2025. PMID: 38490854 Clinical Trial.